Particularly, patients on specific therapy with left ventricular hypertrophy exhibited increased NT-proBNP levels in contrast to those without these two factors (ANOVA: p = 0.026, Figure 1B). This evidence concerns the gene NPPB and left ventricular hypertrophy.